## Abstract ## Background Human papillomavirus (HPV), a cause of oropharyngeal carcinoma, has also been implicated as an etiologic agent in nasopharyngeal carcinomas. ## Methods We performed p16 immunohistochemistry and in situ hybridization for Epstein–Barr virus (EBV) and HPV on 45 carcinomas
Human papillomavirus and WHO type I nasopharyngeal carcinoma
✍ Scribed by Emily J. Lo; Diana Bell; Jason S. Woo; Guojun Li; Ehab Y. Hanna; Adel K. El-Naggar; Erich M. Sturgis
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 121 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objectives:
Nasopharyngeal carcinoma (NPC) is a rare cancer in the United States. An association between NPC and Epstein‐Barr virus (EBV) is well‐established for World Health Organization (WHO) types II and III (WHO‐II/III) NPC but less well‐established for WHO type I (WHO‐I) NPC. Given the rise in oropharyngeal tumors positive for high‐risk human papillomavirus (HPV) and the unique biology of WHO‐I NPC, we examined the relationship between HPV and WHO‐I NPC.
Study Design:
Retrospective case‐comparison study.
Methods:
A search of a large multidisciplinary cancer center tumor registry identified 183 patients seen from January 1999 to December 2008 with incident NPC and no prior cancer. Available paraffin‐embedded tumor specimens (N = 30) were analyzed for oncogenic HPV status by in situ hybridization (ISH) and polymerase chain reaction (PCR) for HPV‐16 and HPV‐18; EBV status by ISH; and p16 expression by immunohistochemistry. Demographic parameters, including race and smoking, were obtained from the medical records.
Results:
Among the 18 WHO‐I NPC patients, 66% (N = 12) were smokers and 17% (N = 3) Asian; among the 165 WHO‐II/III NPC patients, 44% (N = 73) were smokers and 24% (N = 39) Asian. Eight WHO‐I NPC patients had available paraffin blocks; five of six were HPV‐16‐positive by PCR and four of eight were HPV‐positive by ISH; only two of eight (25%) were EBV‐positive. Twenty‐two WHO‐II/III NPC patients had available paraffin blocks; only 1 was HPV‐positive by ISH, and 13 of 22 (60%) were EBV‐positive.
Conclusions:
These results suggest that WHO‐I NPC is associated with oncogenic HPV, although larger studies are needed to verify these findings. Laryngoscope, 2010
📜 SIMILAR VOLUMES
Background. Nasopharyngeal carcinoma (NPC), particularly those tumors endemic to the Far East, commonly harbor Epstein-Barr virus (EBV), thought to serve as an important oncogenic promoter. Human papillomavirus (HPV) is associated with a proportion of upper aerodigestive tract carcinomas. We hypothe
The possible etiological role of human papillomavirus (HPV) in esophageal carcinogenesis was evaluated in Alaska Natives in whom the incidence of esophageal cancer is 1.3 and 3.8 times higher than in US Caucasian men and women, respectively. Fixed paraffin-embedded esophageal tissues from 32 cases o
## Abstract ## BACKGROUND The aim of the current study was to explore the clinical implications and prognostic value of human papillomavirus (HPV) genotype in cervical carcinomas. ## METHODS A total of 152 patients diagnosed with International Federation of Gynecology and Obstetrics Stage I–IV c
Chronic suppurative otitis media, averaging 20 or more years of duration, has been associated with cancer in this region in 40%-80% of cases. Although human papillomaviruses (HPV) have been implicated in many human squamous-cell neoplasms, their role in the pathogenesis of middle-ear malignancies re